Delivery Order SPE2DB22D1017-SPE2DB24FG4UM
Award Date
9/10/24
Potential Completion Date
9/11/24
Potential Value
$9.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $73,379.65 and an ultimate completion date of February 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine to the Defense Logistics Agency (DLA). The $1,368.40 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 9, 2024, with a completion date of May 10, 2024. The contract is under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
The federal contract award is for the provision of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The $1,396.08 firm fixed price delivery order has an ultimate completion date of February 27, 2025 and was awarded on February 26, 2025 to the prime contractor, Amerisourcebergen Drug Corp. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines to the Defense Logistics Agency (DLA). The $5,919.21 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 9, 2025, with a completion date of May 12, 2025. The contract is not set-aside and is part of Amerisourcebergen's broader $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The $11,624.16 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024, with a completion date of December 13, 2024. This is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,174.10, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order placed under an existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award is for the delivery of 4,563,534,948 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine to the Defense Logistics Agency (DLA). The contract, valued at $12,111.58, was awarded on February 2, 2024, with a completion date of February 5, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the procurement of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine, by the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $8,304.07. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award, valued at $28,089.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC allows the DLA to efficiently procure a...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The $2,589.87 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 19, 2025, with a completion date of February 20, 2025. The contract is a delivery order under the DLA's existing Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as...